Skip to main content
ABUS logo
ABUS
(NASDAQ)
Arbutus Biopharma Corporation
$5.15-- (--)
Loading... - Market loading

Arbutus Biopharma (ABUS) Stock Price & Financial Analysis

Arbutus Biopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.09 - $5.17
52-Week High$5.45
52-Week Low$3.50
Open$5.09
Volume5.20M
Average Volume (3M)3.37M
Market Cap1.01B
Shares Outstanding195.21M
P/E Ratio (TTM)6.26
Price to Sales (P/S)5.25
Price to Book (P/B)3.86
EV/EBITDA6.15
Revenue (TTM)191.44M
Net Income (TTM)160.72M
Free Cash Flow (TTM)-42.47M
EPS (TTM)$0.83
Profit Margin83.95%
Operating Margin80.79%
Return on Equity (ROE)61.77%
Debt to Equity0.00
50-Day MA$4.75
200-Day MA$4.49
52-Week Change22.62%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Arbutus Biopharma

What is the current stock price for ABUS?

As of the latest trading session, ABUS stock trades at $5.15. The 52-week range is $3.50–$5.45, with a day range of $5.09–$5.17.

What is the P/E ratio for ABUS?

Arbutus Biopharma's trailing P/E ratio is 6.3, meaning investors pay $6.3 for every $1 of annual earnings. Arbutus Biopharma operates in the Healthcare sector.

Does ABUS pay dividends?

Arbutus Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ABUS?

Based on 2 analysts, the consensus for ABUS is Buy.

What is the market cap of ABUS?

Arbutus Biopharma's market capitalization is $1.01B, classifying it as a small-cap company. Arbutus Biopharma operates in the Healthcare sector within the Biotechnology industry.